Skip to main content
ConductScienceScienceDex

Gustavo Eduardo Velasquez

NIH Rank #42550
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12216834Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$256.5K
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#42,550
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gustavo Eduardo Velasquez. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Gustavo Eduardo Velasquez as a PI. Multi-PI records show the full award amount for context.

  • 1R34AI179568-01R34
    A Phase 2C Randomized, Controlled, Open-Label Trial of Novel Shortened Regimens for the Treatment of Isoniazid-Monoresistant TB (IMR-TB)
    University of California, San Francisco
    $256.5K
    award amount

Award organization

Organizations that administered FY2024 awards listing Gustavo Eduardo Velasquez as a PI.

FY2024 award administered by University of California, San Francisco (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, San Francisco
  2. 2026
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Gustavo Eduardo Velasquez.

Sara Suliman
University of California, San Francisco
1
shared award

Explore further

Find collaborators for Gustavo Eduardo Velasquez

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Gustavo Eduardo Velasquez | NIH Award Records | ConductScience